Literature DB >> 11856758

Role of integrin-linked kinase in leukocyte recruitment.

Erik B Friedrich1, Sumita Sinha, Ling Li, Shoukat Dedhar, Thomas Force, Anthony Rosenzweig, Robert E Gerszten.   

Abstract

Chemokines modulate leukocyte integrin avidity to coordinate adhesion and subsequent transendothelial migration, although the sequential signaling pathways involved remain poorly characterized. Here we show that integrin-linked kinase (ILK), a 59-kDa serine-threonine protein kinase that interacts principally with beta(1) integrins, is highly expressed in human mononuclear cells and is activated by exposure of leukocytes to the chemokine monocyte chemoattractant protein-1. Biochemical inhibitor studies show that chemokine-triggered activation of ILK is downstream of phosphoinositide 3-kinase. In functional assays under physiologically relevant flow conditions, overexpression of wild-type ILK in human monocytic cells diminishes beta(1) integrin/vascular cell adhesion molecule-1-dependent firm adhesion to human endothelial cells. These data implicate ILK in the dynamic signaling events involved in the regulation of leukocyte integrin avidity for endothelial substrates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856758     DOI: 10.1074/jbc.M201240200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis.

Authors:  Chungyee Leung-Hagesteijn; Ming Chang Hu; Ahalya S Mahendra; Sunny Hartwig; Henry J Klamut; Norman D Rosenblum; Gregory E Hannigan
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

2.  Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival.

Authors:  Emerson Liu; Sumita Sinha; Christine Williams; Marcoli Cyrille; Eric Heller; Scott B Snapper; Katia Georgopoulos; Rene St-Arnaud; Thomas Force; Shoukat Dedhar; Robert E Gerszten
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  Integrin-linked kinase regulates endothelial cell survival and vascular development.

Authors:  Erik B Friedrich; Emerson Liu; Sumita Sinha; Stuart Cook; David S Milstone; Calum A MacRae; Massimo Mariotti; Peter J Kuhlencordt; Thomas Force; Anthony Rosenzweig; Rene St-Arnaud; Shoukat Dedhar; Robert E Gerszten
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

4.  gamma-Parvin is dispensable for hematopoiesis, leukocyte trafficking, and T-cell-dependent antibody response.

Authors:  Haiyan Chu; Ingo Thievessen; Michael Sixt; Tim Lämmermann; Ari Waisman; Attila Braun; Angelika A Noegel; Reinhard Fässler
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors.

Authors:  Glenn A Driver; Robin B Veale
Journal:  Cancer Cell Int       Date:  2006-04-27       Impact factor: 5.722

6.  Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation.

Authors:  Diego Rodríguez-Puyol; Laura Calleros; Sofía Campillo; Lourdes Bohorquez; Elena Gutiérrez-Calabrés; Diego García-Ayuso; Verónica Miguel; Mercedes Griera; Yolanda Calle; Sergio de Frutos; Manuel Rodríguez-Puyol
Journal:  Exp Mol Med       Date:  2022-03-04       Impact factor: 12.153

7.  Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes.

Authors:  Leonieke Terpstra; Josée Prud'homme; Alice Arabian; Shu Takeda; Gérard Karsenty; Shoukat Dedhar; René St-Arnaud
Journal:  J Cell Biol       Date:  2003-06-30       Impact factor: 10.539

Review 8.  Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis.

Authors:  Cimona V Hinton; Shalom Avraham; Hava Karsenty Avraham
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.